CMS will monitor Medicare plans’ use of utilization management, and they are required to have the negotiated drugs on formulary, but the ‘ultimate question’ is how the plans will cover these negotiated drugs.

CMS now supporting the basic premium more because IRA-related improvements have reduced the need for additional benefit enhancements traditionally offered by enhanced alternative Part D plans.